Long-acting reversible contraceptive (LARC) continuation rates were high and similar across age and parity and clinicians should not hesitate to recommend LARC methods to young nulliparous females, according to a study of 6,106 participants, including 863 aged 14 to 19 years. The analysis focuses on continuation of the intrauterine device and implant in nulliparous adolescents compared with parous, older women. Researchers found:
• LARC continuation rates at 12 months were high and similar between all age-parity groups ranging from 82% to 86%.
• Nulliparous participants using the copper intrauterine device and implant were more likely to discontinue their LARC method (adjusted HR=1.76) than parous participants.
• This was not observed among levonorgestrel intrauterine system users (adjusted HR=1.16).
• Age <20 years was not associated with discontinuation at 12 months (adjusted HR=0.95).
Citation: Abraham M, Zhao Q, Feipert JF. Young age, nulliparity, and continuation of long-acting reversible contraceptive methods. Obstet Gynecol. [Published online ahead of print September 3, 2015]. doi: 10.1097/AOG.0000000000001036.
This Week's Must Reads
Must Reads in Contraception
Bleeding and Spotting with the LNG 13.5 mg IUS, Contraception; ePub 2019 Mar 1; Shimoni, et al
Contraception and Chronic Opioid Prescriptions, Contraception; ePub 2019 Feb 11; Ray-Griffith, et al
Hormonal Contraception & Coexisting Medical Conditions, Obstet Gynecol; ePub 2019 Feb; Allen, et al
Contraceptive Switching & Discontinuation, Am J Obstet Gynecol; ePub 2018 Dec 18; Simmons, et al
Efficacy of a Levonorgestrel 52-mg IU System, Obstet Gynecol; ePub 2018 Dec 4; Teal, et al